Portland, United States, May 30, 2017 -- According to a new report published by Allied Market Research, titled, "Medical Carts Market by Type: Global Opportunity Analysis and Industry Forecast, 2017–2023," the global medical carts market was valued at $571 million in 2016, and is projected to reach $1,302 million by 2023, growing at a CAGR of 12.4% from 2017 to 2023. The emergency cart segment accounted for nearly half share of the total market in 2016.
Medical cart/trolley is a mobile equipment, which consists of a set of shelves, trays, compartments, and drawers for hospital use and medical settings. It carries, dispense, and transport emergency drugs, medicines, medical devices, and medical instruments. Carts are a crucial aspect of medical aid as it provides storing, recording, and dispensing drugs, supplies, and patient information along with patient care. Many carts are designed to supply various surgical and emergency needs depending on the operating room and other medical settings.
The emergency carts segment is expected to dominate the Asia-Pacific medical carts market throughout the forecast period, both in terms of value and volume. China dominated the Asia-Pacific medical carts market in 2016, accounting for more than one-third market share in terms of value, and is projected to continue this trend in the future. In addition, growth in improvement of patient safety and nursing efficiency supplement the market growth. Further, advancement in technologies, such as telemedicine offer lucrative opportunities for the growth of this market. However, lack of skilled professionals, high cost of medical carts, and limited government funding restrain the market growth.
The emergency carts segment is anticipated to maintain its dominance, generating highest revenue throughout the forecast period, owing to the large-scale employment of emergency carts at the time of crisis. This is because emergency carts contain sophisticated devices, such as defibrillators, suction devices, advanced cardiac life support (ACLS), apart from drugs, such as atropine, dopamine and others. In addition, it also includes generic drugs to treat common problems, rapid sequence intubation, and pediatric equipment. However, procedure carts segment is growing at the highest CAGR of 13.0% from 2017 to 2023 in terms of value, as it consists many medical equipment that aid in operating procedures, such as endoscopy, cardiology and others and provides access to essential drugs at the same time.
According to Sriram Radhakrishnan, Team Lead, Healthcare at Allied Market Research, “The need for bedside patient care in various situations, such as in operating rooms and other emergency circumstances, is expected to propel the medical cart market during the forecast period. Innovation in functionality of medical carts that features universal mounting accessory function, RFID (Radio-frequency identification) locking drawers, and dual pull-out workout shelves enhance the utility of the emergency carts. Moreover, growth in healthcare expenditure and investments in the market have encouraged the manufacturers to develop cost-effective and customized medical carts in the developing countries boosting the market growth”
Connect to Analyst @ https://www.alliedmarketresearch.com/connect-to-analyst/2284
KEY FINDINGS OF THE MEDICAL CART MARKET:
- The procedure carts segment is anticipated to grow at the highest growth rate during the forecast period.
- North America dominated the global medical carts market, accounting for maximum share of overall market in 2016.
- Asia-Pacific is exhibited to grow at a higher growth rate of 13.5% during the forecast period in terms of value, owing to the high population base in countries, such as India and China.
- The emergency cart segment dominated the overall market in 2016, growing at a CAGR of 12.3% in terms of value, from 2017 to 2023.
- In terms of both value and volume, China accounted for the largest share in 2016, and is anticipated to maintain this trend throughout the forecast period in Asia-Pacific region.
- UK is expected to grow at a remarkable CAGR of 13.8% in terms of value and 13.2% in terms of volume during the forecast period.
- In terms of volume, procedure carts are anticipated to grow at the highest rate of 12.9% from 2017 to 2023.
Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2284
Asia-Pacific has witnessed highest growth rate for medical carts during the forecast period, and is expected to continue this trend. This is attributed to increase in sizeable population, rise in incidence of diseases and injuries, healthcare infrastructural development, and huge market potential, owing to the arrival of new and robust carts by key players focusing on the emerging markets.
Key players operating in the medical carts market have adopted product launch as their key developmental strategy, and focus on launching innovative products to cater to the consumer requirements and strengthen their market share. The major companies profiled in the report include InterMetro Industries Corporation (A Part of Ali Group), Harloff Company (Harloff Manufacturing Co.), Armstrong Medical, Capsa Solutions LLC., Omnicell Inc., Medline Industries Inc., ITD GmbH, Midmark Corporation, The Bergmann Group, and Life-Medic HealthCare Supplies Pte Ltd.
The other key players in the value chain include Jegna, Herman Miller, Inc., Zhangjiagang Bestran Technology Co. Ltd., Merino International, BiHealthcare, Tianjin Xuhua Medical Equipment Factory, Medical Master, Hua Shuo Plastic Co., Ltd., Joson-Care Enterprise Co., Ltd., and Tonglu Rex Medical Instrument Co., Ltd.
Pankaj Kumar 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free : +1-800-792-5285 UK : + 44-845-528-1300 Hong Kong : + 852-301-84916 India (Pune) : +91 20 66346060 Fax : +1⟨855⟩550-5975 [email protected]


Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 



